Efficacy and safety of Efavirenz 400 mg-based regimens switching from 600 mg-based regimens in people living with HIV with virological suppression in China: a randomized, open-label, non-inferiority study
- Resource Type
- Article
- Source
- In
International Journal of Infectious Diseases April 2022 117:48-55 - Subject
- Language
- ISSN
- 1201-9712